“The best big pharma stocks offer growth potential thanks to strong pipelines, steady income with dependable dividends, and the opportunity to invest in a business that can make a huge positive impact in the lives of millions of people,” advises the author of today’s article, who proceeds to highlight three such pharma stocks that may be among the best picks…
With their shares having surged by more than 484%, 500% and 275%, respectively, the three stocks highlighted in today’s article are three of the best-performing pharmaceutical stocks over the past year – and despite them having already experienced monster moves higher, it may not be too late to get in on these stocks’ gains. For more on these three pharmaceutical…
As the end of the second quarter of 2020 approaches, a number of biopharmaceutical companies have data readouts due – and positive trial data could serve as catalysts for those companies’ stocks. For seven biopharmaceutical companies with impending data readouts – and details on their respective potential catalysts – CLICK HERE.